Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IT-141 |
Synonyms | |
Therapy Description |
IT-141 is composed of a polymer micelle, ITP-101, which contains the hydrophobic drug, SN-38 (irinotecan metabolite), allowing greater solubility and potentially resulting in antitumor activity (PMID: 22187652). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IT-141 | IT141 | IT-141 is composed of a polymer micelle, ITP-101, which contains the hydrophobic drug, SN-38 (irinotecan metabolite), allowing greater solubility and potentially resulting in antitumor activity (PMID: 22187652). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03096340 | Phase I | IT-141 | Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer | Terminated | USA | 0 |